Brinker Capital Investments’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,409
Closed -$231K 2213
2025
Q4
$231K Buy
+1,409
New +$221K ﹤0.01% 1941
2022
Q3
Sell
-1,816
Closed -$295K 1381
2022
Q2
$295K Buy
1,816
+339
+23% +$53.6K 0.01% 1171
2022
Q1
$278K Sell
1,477
-237
-14% -$45K ﹤0.01% 1251
2021
Q4
$454K Buy
1,714
+1
+0.1% +$269 0.01% 1097
2021
Q3
$342K Hold
1,713
0.01% 1096
2021
Q2
$342K Buy
1,713
+34
+2% +$6.6K ﹤0.01% 1150
2021
Q1
$326K Sell
1,679
-1,411
-46% -$289K ﹤0.01% 1031
2020
Q4
$592K Buy
3,090
+1,594
+107% +$290K 0.01% 806
2020
Q3
$221K Buy
+1,496
New +$214K ﹤0.01% 1085

Other funds holding RGEN

Brinker Capital Investments's RGEN Position: Q1 2026 in Review

Brinker Capital Investments sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,409 shares — an estimated $231K sold.

Brinker Capital Investments first reported a position in RGEN in Q3 2020 and held it in 9 quarters. The position peaked at $592K in Q4 2020. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Brinker Capital Investments reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Brinker Capital Investments sold 1,409 Repligen shares in Q1 2026, an estimated $231K.
  • Brinker Capital Investments first reported a position in Repligen in Q3 2020 and held it in 9 quarters.
  • Brinker Capital Investments's Repligen position peaked at $592K in Q4 2020.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.